Trial Profile
A trial to study the effect of glargine and lixisenatide on regulation the compliance and the quality of life of type 2 diabetes patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Sep 2016
Price :
$35
*
At a glance
- Drugs Insulin glargine (Primary) ; Lixisenatide (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 15 Mar 2016 New trial record